Leon Cooperman’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-468,000
Closed -$29.6M – 87
2018
Q1
$29.6M Buy
+468,000
New +$30.1M 1.11% 38

Other funds holding BMY

Leon Cooperman's BMY Position: Q2 2018 in Review

Leon Cooperman sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 468,000 shares — an estimated $29.6M sold.

Leon Cooperman first reported a position in BMY in Q1 2018 and held it in 1 quarter. The position peaked at $29.6M in Q1 2018. 1,689 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Leon Cooperman reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
  • Leon Cooperman sold 468,000 Bristol-Myers Squibb shares in Q2 2018, an estimated $29.6M.
  • Leon Cooperman first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 1 quarter.
  • Leon Cooperman's Bristol-Myers Squibb position peaked at $29.6M in Q1 2018.
  • 1,689 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Cooperman Leon G's 13F filing for Q2 2018, filed 14 Aug 2018.